Prognostic significance of suboptimal secondary prevention pharmacotherapy after acute coronary syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic significance of suboptimal secondary prevention pharmacotherapy after acute coronary syndromes

Published:2021-03 Issue:3 Volume:51 Page:366-374
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Yudi Matias B.¹²,Farouque Omar¹²,Andrianopoulos Nick³,Ajani Andrew E.²³⁴,Brennan Angela³,Murphy Alexandra C.¹²^ORCID,Lefkovits Jeffrey³⁴,Reid Christopher M.³⁵,Oqueli Ernesto⁶,Sebastian Martin⁷,Duffy Stephen J.³⁸^ORCID,Clark David J.¹²,

Affiliation:

1. Department of Cardiology Austin Health Melbourne Victoria Australia

2. Department of Medicine University of Melbourne Melbourne Victoria Australia

3. Centre of Cardiovascular Research and Education in Therapeutics (CCRE) Monash University Melbourne Victoria Australia

4. Department of Cardiology Royal Melbourne Hospital Melbourne Victoria Australia

5. School of Public Health, Curtin University Perth Western Australia Australia

6. Department of Cardiology Ballarat Base Hospital Ballarat Victoria Australia

7. Department of Cardiology Barwon Health Geelong Victoria Australia

8. Department of Cardiology Alfred Health Melbourne Victoria Australia

Funder

National Health and Medical Research Council

National Heart Foundation of Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.14750

Reference41 articles.

1. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

2. Association of Temporal Trends in Risk Factors and Treatment Uptake With Coronary Heart Disease Mortality, 1994-2005

3. Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge

4. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

5. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia;Heart, Lung and Circulation;2024-07

2. Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database;European Journal of Preventive Cardiology;2023-12-22

3. Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia;European Journal of Preventive Cardiology;2023-11-21

4. Did Australia's COVID-19 Restrictions Impact Statin Incidence, Prevalence or Adherence?;Current Problems in Cardiology;2023-04

5. Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study;International Journal of Clinical Pharmacy;2023-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3